gamma-Hydroxybutyric acid
gamma-Hydroxybutyric acid (or γ-hydroxybutyric acid (GHB), also known as 4-hydroxybutanoic acid) is a naturally occurring neurotransmitter and a depressant drug. It is a precursor to GABA, glutamate, and glycine in certain brain areas. It acts on the GHB receptor and is a weak agonist at the GABAB receptor. GHB has been used in the medical setting as a general anesthetic and as treatment for cataplexy, narcolepsy, and alcoholism. The substance is also used illicitly for various reasons, including as a performance-enhancing drug, date rape drug, and as a recreational drug.
Clinical data | |
---|---|
Other names |
|
Routes of administration | By mouth, intravenous |
Drug class | Depressant, Sedative, Psycholeptic, Hypnotic, GABA analogue |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 25% (oral) |
Metabolism | 95%, mainly liver, also in blood and tissues |
Onset of action | Within 5–15 minutes |
Elimination half-life | 30–60 minutes |
Excretion | 5%, kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.218.519 |
Chemical and physical data | |
Formula | C4H8O3 |
Molar mass | 104.105 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
It is commonly used in the form of a salt, such as sodium γ-hydroxybutyrate (NaGHB, sodium oxybate, or Xyrem) or potassium γ-hydroxybutyrate (KGHB, potassium oxybate). GHB is also produced as a result of fermentation, and is found in small quantities in some beers and wines, beef, and small citrus fruits.
Succinic semialdehyde dehydrogenase deficiency is a disease that causes GHB to accumulate in the blood.